CapForce Inc.
CFOR- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001293818
No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in CapForce Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q3 2022
- Shares held
- 2.14M
- −6.64M (−75.6%) vs. Q3 2022
- Total value
- $521.8K
- −$1.99M (−79.3%) vs. Q3 2022
- New holders
- 8
- 4 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CFOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $6 |
| Q2 2024 | 7 | $12.3K |
| Q1 2024 | 13 | $322.1K |
| Q4 2023 | 17 | $123.7K |
| Q3 2023 | 14 | $121.5K |
| Q2 2023 | 12 | $586.6K |
| Q1 2023 | 16 | $329.2K |
| Q4 2022 | 26 | $521.8K |
| Q3 2022 | 23 | $2.52M |
| Q2 2022 | 25 | $1.88M |
| Q1 2022 | 28 | $3.08M |
| Q4 2021 | 31 | $5.11M |
| Q3 2021 | 23 | $8.44M |
| Q2 2021 | 28 | $5.31M |
| Q1 2021 | 31 | $5.06M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding CapForce Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | 82,500 | $232.0K | 0.33% | +82,500 | New |
| Vanguard Group Inc | 466,656 | $65.8K | 0.00% | −1,410,941−75.1% | Reduced |
| Geode Capital Management, LLC | 361,863 | $51.0K | 0.00% | −817−0.2% | Reduced |
| BlackRock Inc. | 320,804 | $45.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 191,437 | $26.0K | 0.00% | +191,437 | New |
| Renaissance Technologies LLC | 173,400 | $24.0K | 0.00% | +55,900+47.6% | Added |
| State Street Corp | 129,200 | $18.2K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 128,748 | $18.2K | 0.00% | +128,748 | New |
| Northern Trust Corp | 69,789 | $9.84K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 34,000 | $4.79K | 0.00% | +1,000+3.0% | Added |
| Bank of New York Mellon Corp | 28,242 | $3.98K | 0.00% | −12,234−30.2% | Reduced |
| Great Valley Advisor Group, Inc. | 25,100 | $3.54K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 17,983 | $3.00K | 0.00% | −2,747−13.3% | Reduced |
| Goldman Sachs Group Inc | 20,638 | $2.91K | 0.00% | +20,638 | New |
| Two Sigma Securities, LLC | 19,986 | $2.82K | 0.00% | +19,986 | New |
| Jane Street Group, LLC | 19,309 | $2.72K | 0.00% | −504−2.5% | Reduced |
| Sigma Planning Corp | 17,500 | $2.47K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14,361 | $2.01K | 0.00% | −53,676−78.9% | Reduced |
| Millennium Management LLC | 11,304 | $2.00K | 0.00% | +11,304 | New |
| Morgan Stanley | 7,010 | $988 | 0.00% | +7,010 | New |
| FMR LLC | 1,000 | $141 | 0.00% | +1,000 | New |
| Focused Wealth Management, Inc | 500 | $71 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 367 | $52 | 0.00% | +45+14.0% | Added |
| Bank of America Corp | 162 | $23 | 0.00% | −100−38.2% | Reduced |
| Royal Bank of Canada | 1,600 | $0 | 0.00% | +600+60.0% | Added |
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −5,300,000−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −100,773−100.0% | Sold out |
| Allen Capital Group, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Valley National Advisers Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |